Nanobiotix prices oversubscribed €85 million follow-on offering at $38.98 per ADS

  • Nanobiotix priced an oversubscribed €85 million global follow-on offering, split between 225,373 ADSs at USD 38.98 each in the U.S. tranche and 1,959,289 ordinary shares at EUR 33.6 each in the international tranche.
  • The deal also includes 345,099 pre-funded warrants priced at EUR 33.57 each, exercisable for one ordinary share at EUR 0.03 through May 26, 2036.
  • Gross proceeds are expected to total about USD 98.6 million, including about EUR 11.6 million from the pre-funded warrants, before fees and expenses.
  • The underwriters hold a 30-day option to buy up to 15% additional ADSs, implying gross proceeds of about USD 100 million if fully exercised.
  • Net proceeds are earmarked mainly for Nanoprimer and other platforms, with a smaller allocation to JNJ-1900 (NBTXR3) and the balance for general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nanobiotix SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605211057PRIMZONEFULLFEED9724782) on May 21, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.